C3orf34_1500031L02Rik Inhibitors
The elusive nature of C3orf34's function necessitates an exploratory approach in identifying modulatory compounds. Within the cellular milieu, a series of signaling pathways govern the physiological responses. For instance, the phosphatidylinositol 3-kinase (PI3K) pathway, which can be modulated by inhibitors such as Wortmannin and LY294002, serves as a vital communicator in cellular growth and survival. Any association of C3orf34 with this pathway suggests its indirect modulation through these inhibitors.
Similarly, the MAPK/ERK signaling cascade, a fundamental controller of cellular proliferation, can be dampened using inhibitors like PD98059 and U0126. If C3orf34 functions within this cascade or even downstream, its activity can be influenced. Broad-spectrum inhibitors, such as Staurosporine, offer a unique opportunity to modulate proteins with not yet fully elucidated roles like C3orf34. Given the diversity of cellular signaling, understanding the intricate network and pinpointing exact modulatory compounds for such proteins is challenging yet crucial. The given inhibitors provide a foundational step towards comprehending the modulation of C3orf34, underlining the importance of continued research in this domain.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
PI3K inhibitor that disrupts the phosphatidylinositol 3-kinase pathway. If C3orf34 is linked to this pathway, its function can be indirectly modulated by Wortmannin. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
Another PI3K inhibitor that affects the PI3K-AKT pathway. Any proteins associated with this pathway, including potentially C3orf34, can be indirectly influenced. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor that impacts the c-Jun N-terminal kinase pathway. If C3orf34 functions within or downstream of this pathway, its activity can be modulated by SP600125. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
MEK inhibitor that suppresses the MAPK/ERK pathway. Proteins functioning within this pathway, possibly including C3orf34, can be indirectly affected. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
mTOR inhibitor that disrupts the mTOR signaling pathway. This can indirectly modulate the function of proteins associated with mTOR signaling, potentially including C3orf34. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
p38 MAPK inhibitor. If C3orf34 operates in the p38 MAPK pathway, its activity can be indirectly modulated by this compound. | ||||||
Z-VAD-FMK | 187389-52-2 | sc-3067 | 500 µg | $74.00 | 256 | |
Pan-caspase inhibitor that influences apoptosis. If C3orf34 is linked to apoptotic processes, its function can be indirectly modulated by this compound. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
Broad-spectrum kinase inhibitor. Given its wide range of targets, it can potentially modulate the function of proteins with unclear functions, such as C3orf34. | ||||||
Tyrphostin B42 | 133550-30-8 | sc-3556 | 5 mg | $26.00 | 4 | |
JAK2 inhibitor that affects the JAK-STAT signaling pathway. If C3orf34 operates within this pathway, its function can be indirectly influenced. | ||||||
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $99.00 $335.00 $836.00 $2099.00 | 47 | |
Gamma-secretase inhibitor affecting the Notch signaling pathway. Potential associations of C3orf34 with this pathway can be indirectly modulated by DAPT. | ||||||